These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 36341336)

  • 21. NLRC3 is an inhibitory sensor of PI3K-mTOR pathways in cancer.
    Karki R; Man SM; Malireddi RKS; Kesavardhana S; Zhu Q; Burton AR; Sharma BR; Qi X; Pelletier S; Vogel P; Rosenstiel P; Kanneganti TD
    Nature; 2016 Dec; 540(7634):583-587. PubMed ID: 27951586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpressed NLRC3 acts as an anti-inflammatory cytosolic protein.
    Gültekin Y; Eren E; Özören N
    J Innate Immun; 2015; 7(1):25-36. PubMed ID: 25277106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NLRC3 promotes host resistance against Pseudomonas aeruginosa-induced keratitis by promoting the degradation of IRAK1.
    Guo L; Kong Q; Dong Z; Dong W; Fu X; Su L; Tan X
    Int J Mol Med; 2017 Sep; 40(3):898-906. PubMed ID: 28731142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An anti-inflammatory NOD-like receptor is required for microglia development.
    Shiau CE; Monk KR; Joo W; Talbot WS
    Cell Rep; 2013 Dec; 5(5):1342-52. PubMed ID: 24316075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NLRC3 puts the brakes on STING.
    Mangan MS; Latz E
    Immunity; 2014 Mar; 40(3):305-6. PubMed ID: 24656040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NLRC3 alleviates hypoxia/reoxygenation induced inflammation in RAW264.7 cells by inhibiting K63-linked ubiquitination of TRAF6.
    Li ZT; Liu H; Zhang WQ
    Hepatobiliary Pancreat Dis Int; 2020 Oct; 19(5):455-460. PubMed ID: 32386989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of NLRC3 enhanced inhibition effect of sevoflurane on inflammation in an ischaemia reperfusion cell model.
    Li W; Zhang Y; Hu Z; Xu Y
    Folia Neuropathol; 2020; 58(3):213-222. PubMed ID: 33099291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NOD-Like Receptors in Infection, Immunity, and Diseases.
    Kim YK; Shin JS; Nahm MH
    Yonsei Med J; 2016 Jan; 57(1):5-14. PubMed ID: 26632377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The innate immune sensor NLRC3 attenuates Toll-like receptor signaling via modification of the signaling adaptor TRAF6 and transcription factor NF-κB.
    Schneider M; Zimmermann AG; Roberts RA; Zhang L; Swanson KV; Wen H; Davis BK; Allen IC; Holl EK; Ye Z; Rahman AH; Conti BJ; Eitas TK; Koller BH; Ting JP
    Nat Immunol; 2012 Sep; 13(9):823-31. PubMed ID: 22863753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NLRC3 negatively regulates Pasteurella multocida-induced NF-κB signaling in rabbits.
    Guo M; Zhang J; Li M; Zhang X; Wu Y
    Dev Comp Immunol; 2024 Jan; 150():105078. PubMed ID: 37820760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unsolved Mysteries in NLR Biology.
    Lupfer C; Kanneganti TD
    Front Immunol; 2013 Sep; 4():285. PubMed ID: 24062750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NLRC3 deficiency promotes cutaneous wound healing due to the inhibition of p53 signaling.
    Qin Y; Wu K; Zhang Z; Pan R; Lin Z; Zhang W; Huang S; Dai J; Huang R; Gong S; Lin H; Chong S; Lu L; Lu X
    Biochim Biophys Acta Mol Basis Dis; 2022 Nov; 1868(11):166518. PubMed ID: 35963285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NOD-like receptors and inflammasomes: A review of their canonical and non-canonical signaling pathways.
    Platnich JM; Muruve DA
    Arch Biochem Biophys; 2019 Jul; 670():4-14. PubMed ID: 30772258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NLRC3 inhibits PDGF-induced PASMCs proliferation via PI3K-mTOR pathway.
    Zha LH; Zhou J; Tan Y; Guo S; Zhang MQ; Li S; Yan P; Yu ZX
    J Cell Physiol; 2020 Dec; 235(12):9557-9567. PubMed ID: 32383265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Butyrate ameliorated-NLRC3 protects the intestinal barrier in a GPR43-dependent manner.
    Cheng D; Xu JH; Li JY; Wang SY; Wu TF; Chen QK; Yu T
    Exp Cell Res; 2018 Jul; 368(1):101-110. PubMed ID: 29689277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in Understanding Activation and Function of the NLRC4 Inflammasome.
    Sundaram B; Kanneganti TD
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The correlation of NLRC3 expression with the progression and prognosis of hepatocellular carcinoma.
    Ma YY; Zhang GH; Li J; Wang SB; Hu ZM; Zhang CW; Li E
    Hum Pathol; 2018 Dec; 82():273-281. PubMed ID: 30081150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and characterization of a novel NOD-like receptor family CARD domain containing 3 gene in response to extracellular ATP stimulation and its role in regulating LPS-induced innate immune response in Japanese flounder (Paralichthys olivaceus) head kidney macrophages.
    Li S; Chen X; Hao G; Geng X; Zhan W; Sun J
    Fish Shellfish Immunol; 2016 Mar; 50():79-90. PubMed ID: 26820104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression profiles of NOD-like receptors and regulation of NLRP3 inflammasome activation in Toxoplasma gondii-infected human small intestinal epithelial cells.
    Chu JQ; Gao FF; Wu W; Li C; Pan Z; Sun J; Wang H; Huang C; Lee SH; Quan JH; Lee YH
    Parasit Vectors; 2021 Mar; 14(1):153. PubMed ID: 33712075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization and expression profiling of NOD-like receptor C3 (NLRC3) in mucosal tissues of turbot (Scophthalmus maximus L.) following bacterial challenge.
    Hou Z; Ye Z; Zhang D; Gao C; Su B; Song L; Tan F; Song H; Wang Y; Li C
    Fish Shellfish Immunol; 2017 Jul; 66():231-239. PubMed ID: 28478262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.